DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors Despite Daily Gains
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ rallied 1.36% to $510.08 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.59% to 7,811.54 and the Dow Jones Industrial Average rising 0.83% to 51,654.95.
Vertex Pharmaceuticals Inc. closed 8.95% short of its 52-week high of $560.25, which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ rose 1.49% to $276.47, Krystal Biotech Inc. (KRYS) rose 1.32% to $331.61, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 6.76% to $13.74.
Trading volume (1.5 M) eclipsed its 50-day average volume of 1.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 9, 2026.